The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Refractory Epilepsy: Clinical Overview
Open accessAbstract
Summary: The incidence of refractory epilepsy remains high despite the influx of many new antiepileptic drugs (AEDs) over the past 10 years. Epidemiological data indicate that 20–40% of the patients with newly diagnosed epilepsy will become refractory to treatment. Factors that may be used to predict whether or not a patient will respond favorably to AED therapy include the type of epilepsy, underlying syndrome, etiology, and the patient's history of seizure frequency, density, and clustering. Environmental factors, such as trauma and prior drug exposure, and genetic factors that predetermine the rate of absorption, metabolism, and uptake of a drug by target tissue may also uniquely impact an individual and influence their response to AED therapy. Treatment resistance is, therefore, a multifaceted phenomenon. Since individuals with refractory epilepsy do not share a common reason for their treatment resistance, the use of targeted drug therapies may be our best option for improving treatment outcomes in this patient population. Pharmacogeneticists are currently attempting to understand the genetic basis of refractory epilepsy so that they can identify subgroups of patients who share a common genetic background and then target drug therapies to meet their specific needs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Early Identification of Refractory Epilepsy
Kwan, P., & Brodie, M. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002033420503 · Cited by 5,204
Is the underlying cause of epilepsy a major prognostic factor for recurrence?
Semah, F., Picot, M.-C., Adam, C., Broglin, D., Arzimanoglou, A., Bazin, B., Cavalcanti, D., & Baulac, M. (1998) · Neurology · doi:10.1212/wnl.51.5.1256 · Cited by 1,113
Levetiracetam for partial seizures: Results of a double-blind, randomized clinical trial
Cereghino, J. J., Biton, V., Abou-Khalil, B., Dreifuss, F., Gauer, L. J., Leppik, I., & the United States Levetiracetam Study Group (2000) · Neurology · doi:10.1212/wnl.55.2.236 · Cited by 524
Marson, A., Jacoby, A., Johnson, A., Kim, L., Gamble, C., & Chadwick, D. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66694-9 · Cited by 438
French, J. A., Kanner, A. M., Bautista, J., Abou-Khalil, B., Browne, T., Harden, C. L., Theodore, W. H., Bazil, C., Stern, J., Schachter, S. C., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000123695.22623.32 · Cited by 407
Self-citationRisk of Recurrent Seizures after Two Unprovoked Seizures
Hauser, W. A., Rich, S. S., Lee, J. R.-J., Annegers, J. F., & Anderson, V. E. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380704 · Cited by 387
Early development of intractable epilepsy in children: A prospective study
Berg, A. T., Shinnar, S., Levy, S. R., Testa, F. M., Smith–Rapaport, S., & Beckerman, B. (2001) · Neurology · doi:10.1212/wnl.56.11.1445 · Cited by 379
Berg, A. T., & Shinnar, S. (1996) · Epilepsia · doi:10.1111/j.1528-1157.1996.tb00003.x · Cited by 341
Cockerell, O. C., Johnson, A. L., Sander, J. W. A. S., & Shorvon, S. D. (1997) · Epilepsia · doi:10.1111/j.1528-1157.1997.tb01075.x · Cited by 311
How long does it take for partial epilepsy to become intractable?
Berg, A. T., Langfitt, J., Shinnar, S., Vickrey, B. G., Sperling, M. R., Walczak, T., Bazil, C., Pacia, S. V., & Spencer, S. S. (2003) · Neurology · doi:10.1212/01.wnl.0000031792.89992.ec · Cited by 305
Cited by
Epilepsy and Cognitive Impairments in Alzheimer Disease
Palop, J. J. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.15 · Cited by 684
Structural brain abnormalities in the common epilepsies assessed in a worldwide ENIGMA study
Whelan, C. D., Altmann, A., Botía, J. A., Jahanshad, N., Hibar, D. P., Absil, J., Alhusaini, S., Alvim, M. K. M., Auvinen, P., Bartolini, E., et al. (2018) · Brain · doi:10.1093/brain/awx341 · Cited by 531
Drug-Resistant Epilepsy: Multiple Hypotheses, Few Answers
Tang, F., Hartz, A. M. S., & Bauer, B. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00301 · Cited by 482
Patsalos, P. N. (2015) · Epilepsia · doi:10.1111/epi.12865 · Cited by 272
Managing drug-resistant epilepsy: challenges and solutions
Dalic, L., & Cook, M. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s84852 · Cited by 258
Metadata
- Authors
- French, J. A.
- Venue
- Epilepsia
- Publisher
- Wiley
- Published
- 2007-02-21
- Volume
- 48
- Issue
- s1
- Pages
- 3-7
- ISSN
- 0013-9580 (ISSN-L)
- 1528-1167
- OpenAlex
- W2045549224
- Cited by
- 430
- References
- 26
- FWCI
- 10.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Refractory Epilepsy: Clinical Overview. https://app.cochat.ai/papers/10.1111/j.1528-1167.2007.00992.x
- The paper
- French, J. A. (2007). Refractory Epilepsy: Clinical Overview. Epilepsia. https://doi.org/10.1111/j.1528-1167.2007.00992.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.